新型isatin-肟醚类IDH1抑制剂的设计、合成、生物学评价及分子对接。

IF 3.9 2区 化学 Q2 CHEMISTRY, APPLIED Molecular Diversity Pub Date : 2025-01-02 DOI:10.1007/s11030-024-11084-4
Kangning Wei, Kaige Guo, Ye Tao, Xuanming Gong, Guobing Yan, Liangliang Wang, Ming Guo
{"title":"新型isatin-肟醚类IDH1抑制剂的设计、合成、生物学评价及分子对接。","authors":"Kangning Wei, Kaige Guo, Ye Tao, Xuanming Gong, Guobing Yan, Liangliang Wang, Ming Guo","doi":"10.1007/s11030-024-11084-4","DOIUrl":null,"url":null,"abstract":"<p><p>A series of novel isatin-oxime ether derivatives were designed, synthesized and characterized by <sup>1</sup>H NMR and <sup>13</sup>C NMR and HRMS. These compounds were evaluated for their in vitro cytotoxicity against three human cancer cell lines (A549, HepG2 and Hela) by MTT assay. According to the experimental results, compounds 6a (IC<sub>50</sub> = 0.34μM), 6c (IC<sub>50</sub> = 14nM) and 6r (IC<sub>50</sub> = 45nM) were found as the excellent selectivity and high activity against A549, whereas compounds 6m (IC<sub>50</sub> = 12nM) and 6n (IC<sub>50</sub> = 25nM) displayed the significant activity for HepG2, respectively. Compound 6f (IC<sub>50</sub> = 30nM), 6n (IC<sub>50</sub> = 9nM) and 6o (IC<sub>50</sub> = 20nM) also showed the excellent activity against Hela. From the experiments of cell migration and colony formation assays, the findings demonstrated that 6m can effectively suppress the migration and growth of HepG2 cells. In addition, the results of molecular docking studies determined the strong binding interactions between the potential active compounds 6m and 6n and the active sites of isocitrate dehydrogenase 1 (IDH1) with the lowest binding affinity energy.</p>","PeriodicalId":708,"journal":{"name":"Molecular Diversity","volume":" ","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design, synthesis, biological evaluation and molecular docking of novel isatin-oxime ether derivatives as potential IDH1 inhibitors.\",\"authors\":\"Kangning Wei, Kaige Guo, Ye Tao, Xuanming Gong, Guobing Yan, Liangliang Wang, Ming Guo\",\"doi\":\"10.1007/s11030-024-11084-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A series of novel isatin-oxime ether derivatives were designed, synthesized and characterized by <sup>1</sup>H NMR and <sup>13</sup>C NMR and HRMS. These compounds were evaluated for their in vitro cytotoxicity against three human cancer cell lines (A549, HepG2 and Hela) by MTT assay. According to the experimental results, compounds 6a (IC<sub>50</sub> = 0.34μM), 6c (IC<sub>50</sub> = 14nM) and 6r (IC<sub>50</sub> = 45nM) were found as the excellent selectivity and high activity against A549, whereas compounds 6m (IC<sub>50</sub> = 12nM) and 6n (IC<sub>50</sub> = 25nM) displayed the significant activity for HepG2, respectively. Compound 6f (IC<sub>50</sub> = 30nM), 6n (IC<sub>50</sub> = 9nM) and 6o (IC<sub>50</sub> = 20nM) also showed the excellent activity against Hela. From the experiments of cell migration and colony formation assays, the findings demonstrated that 6m can effectively suppress the migration and growth of HepG2 cells. In addition, the results of molecular docking studies determined the strong binding interactions between the potential active compounds 6m and 6n and the active sites of isocitrate dehydrogenase 1 (IDH1) with the lowest binding affinity energy.</p>\",\"PeriodicalId\":708,\"journal\":{\"name\":\"Molecular Diversity\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-01-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Diversity\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://doi.org/10.1007/s11030-024-11084-4\",\"RegionNum\":2,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, APPLIED\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Diversity","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1007/s11030-024-11084-4","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0

摘要

设计、合成了一系列新的异辛肟醚衍生物,并通过1H NMR、13C NMR和HRMS对其进行了表征。采用MTT法对3种人癌细胞(A549、HepG2和Hela)的体外细胞毒性进行了评价。实验结果表明,化合物6a (IC50 = 0.34μM)、6c (IC50 = 14nM)和6r (IC50 = 45nM)对A549具有较好的选择性和较高的活性,而化合物6m (IC50 = 12nM)和6n (IC50 = 25nM)对HepG2具有较强的活性。化合物6f (IC50 = 30nM)、6n (IC50 = 9nM)和60 (IC50 = 20nM)也表现出良好的抗Hela活性。通过细胞迁移实验和集落形成实验,发现6m能有效抑制HepG2细胞的迁移和生长。此外,分子对接研究结果确定了潜在活性化合物6m和6n与异柠檬酸脱氢酶1 (IDH1)活性位点之间具有较强的结合相互作用,结合亲和能最低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Design, synthesis, biological evaluation and molecular docking of novel isatin-oxime ether derivatives as potential IDH1 inhibitors.

A series of novel isatin-oxime ether derivatives were designed, synthesized and characterized by 1H NMR and 13C NMR and HRMS. These compounds were evaluated for their in vitro cytotoxicity against three human cancer cell lines (A549, HepG2 and Hela) by MTT assay. According to the experimental results, compounds 6a (IC50 = 0.34μM), 6c (IC50 = 14nM) and 6r (IC50 = 45nM) were found as the excellent selectivity and high activity against A549, whereas compounds 6m (IC50 = 12nM) and 6n (IC50 = 25nM) displayed the significant activity for HepG2, respectively. Compound 6f (IC50 = 30nM), 6n (IC50 = 9nM) and 6o (IC50 = 20nM) also showed the excellent activity against Hela. From the experiments of cell migration and colony formation assays, the findings demonstrated that 6m can effectively suppress the migration and growth of HepG2 cells. In addition, the results of molecular docking studies determined the strong binding interactions between the potential active compounds 6m and 6n and the active sites of isocitrate dehydrogenase 1 (IDH1) with the lowest binding affinity energy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Diversity
Molecular Diversity 化学-化学综合
CiteScore
7.30
自引率
7.90%
发文量
219
审稿时长
2.7 months
期刊介绍: Molecular Diversity is a new publication forum for the rapid publication of refereed papers dedicated to describing the development, application and theory of molecular diversity and combinatorial chemistry in basic and applied research and drug discovery. The journal publishes both short and full papers, perspectives, news and reviews dealing with all aspects of the generation of molecular diversity, application of diversity for screening against alternative targets of all types (biological, biophysical, technological), analysis of results obtained and their application in various scientific disciplines/approaches including: combinatorial chemistry and parallel synthesis; small molecule libraries; microwave synthesis; flow synthesis; fluorous synthesis; diversity oriented synthesis (DOS); nanoreactors; click chemistry; multiplex technologies; fragment- and ligand-based design; structure/function/SAR; computational chemistry and molecular design; chemoinformatics; screening techniques and screening interfaces; analytical and purification methods; robotics, automation and miniaturization; targeted libraries; display libraries; peptides and peptoids; proteins; oligonucleotides; carbohydrates; natural diversity; new methods of library formulation and deconvolution; directed evolution, origin of life and recombination; search techniques, landscapes, random chemistry and more;
期刊最新文献
Synthesis and antifungal activity of arecoline derivatives containing amino acid fragments. Discovery of selective ROCK2 inhibitors with free radical scavenging ability for the treatment of gouty arthritis. Targeting cyclin-dependent kinase 11: a computational approach for natural anti-cancer compound discovery. Synthesis and biological evaluation of rationally designed pyrazoles as insecticidal agents. Optimizing kinase and PARP inhibitor combinations through machine learning and in silico approaches for targeted brain cancer therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1